Physician profile
Michaela Hickey
NPI 1194088690
$3,107.17
in general payments reported to CMS, 2019-2025
22 companies · $1,380 in 2025
The $1,380 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $180 · 2021: $47.62 · 2022: $237 · 2023: $221 · 2024: $663 · 2025: $1,380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,264.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $976.11 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Biotissue Holdings INC. | $482.17 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $303.08 | 2019-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $274.90 | 2020-2023 | Acthar |
| Bausch & Lomb Americas INC. | $141.31 | 2024-2025 | Miebo, Vyzulta, Xiidra |
| Tarsus Pharmaceuticals, INC. | $117.87 | 2024-2025 | Xdemvy |
| Abbvie INC. | $108.66 | 2022-2025 | |
| Allergan, INC. | $102.65 | 2019-2021 | |
| Amgen INC. | $88.17 | 2024-2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $79.98 | 2025 | Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $77.95 | 2019-2020 | |
| Dompe US, INC. | $77.63 | 2025 | Oxervate |
| Thea Pharma INC. | $45.55 | 2024-2025 | Iyuzeh |
| Harrow Eye, LLC | $42.86 | 2024 | Ilevro, Vevye |
| Oyster Point Pharma, INC. | $39.63 | 2022-2024 | Ryzumvi, Tyrvaya |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $36.14 | 2019 | |
| Omeros Corporation | $31.59 | 2019 | |
| New World Medical,INC. | $20.96 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.68 | 2020 | |
| Sight Sciences, INC. | $13.61 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Horizon Therapeutics Plc | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Hickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.